Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Gastroparesis Clinical Trials

A listing of Gastroparesis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

METO-IN-004 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men with symptoms associated with Diabetic Gastroparesis.

Phase

METO-IN-003 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women with symptoms associated with Diabetic Gastroparesis.

Phase

We are enrolling volunteers for a clinical research study evaluating the safety and efficacy of an investigational drug for individuals with Diabetic Gastroparesis. Qualified participants must: Ages 18 to 75 Have Diabetes Type 1 or 2 at least 5 years Have symptoms of nausea or vomiting, abdominal pain, bloating or ...

Phase

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis

This study will evaluate the safety and efficacy of Relamorelin compared to placebo in patients with diabetic gastroparesis. Patients will report daily severity scores of their diabetic gastroparesis symptoms.

Phase

Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02

This study will evaluate the safety and efficacy of Relamorelin compared to placebo in patients with diabetic gastroparesis. Patients will report daily severity scores of their diabetic gastroparesis symptoms.

Phase

Domperidone in Treating Patients With Gastrointestinal Disorders

PRIMARY OBJECTIVES: I. To provide treatment with domperidone to patients >= 16 years of age where, according to the investigators' judgment, a prokinetic effect is needed for the relief of gastrointestinal (GI) motility disorders. OUTLINE Patients receive domperidone orally (PO) thrice daily (TID) or four times daily (QID). Treatment continues ...

Phase

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

A 52-week study to compare the efficacy of relamorelin with that of placebo in participants with diabetic gastroparesis (DG) with respect to the core signs and symptoms of diabetic gastroparesis.

Phase